Editor: Atta-ur-Rahman

Frontiers in Clinical Drug Research - Alzheimer Disorders

Volume 4

eBook: US $129 Special Offer (PDF + Printed Copy): US $219
Printed Copy: US $155
Library License: US $516
ISSN: 2451-8743 (Print)
ISSN: 2214-5168 (Online)
ISBN: 978-1-68108-148-9 (Print)
ISBN: 978-1-68108-147-2 (Online)
Year of Publication: 2015
DOI: 10.2174/97816810814721150401

Introduction

Frontiers in Clinical Drug Research - Alzheimer Disorders is an e-Book series concerned with Alzheimer's disease (AD) that causes dementia, or loss of brain function. The disease affects the parts of the brain that deal with memory, thought, and language. Chapters in each volume focus on (Alzheimer Disorders) drug research with special emphasis on clinical trials, research on drugs in advanced stages of development and cure for Alzheimer’s disease and related disorders.

Frontiers in Clinical Drug Research - Alzheimer Disorders will be of particular interest to readers interested in drug therapy of this specific neurodegenerative condition and related brain disorders as the series provides relevant reviews written by experts in field of Alzheimer’s Disease research.

The fourth volume of this series features research on

- Melatoninergic Pathways in Alzheimer's disease,

- Nutritional Approaches in Alzheimer’s disease prevention,

- Updates on drugs and strategies for Alzheimer’s disease prevention

Contributors

Editor(s):
Atta-ur-Rahman FRS
Kings College, University of Cambridge
Cambridge
UK




Contributor(s):
Cheung Toa Ng
School of Biomedical Sciences
The University of Hong Kong, Pokfulam
Hong Kong
China


George Anderson
CRC Scotland & London
Eccleston Square
London
UK


Gordon K. Wilcock
Nuffield Department of Clinical Neurosciences
Oxford University
UK


Leung-Wing Chu
Department of Medicine, LKS Faculty of Medicine
University of Hong Kong, Queen Mary Hospital
Hong Kong
China
/
Alzheimer’s Disease Research Network, SRT Aging
The University of Hong Kong
Hong Kong
China


Lili Chen
Center for Human Tissues and Organs Degeneration
Shenzhen Institute of Advanced Technology, Chinese Academy of Sciences
Shenzhen
China


Liqiu Wang
Department of Mechanical Engineering
The University of Hong Kong
Hong Kong
China
/
HKU-Zhejiang Institute of Research and Innovation (HKU-ZIRI)
Linan 311100
Zhejiang
China


Margaret M. Esiri
Nuffield Department of Clinical Neurosciences
Oxford University
UK


Michael Maes
Department of Psychiatry
Deakin University
Geelong
Australia


Pamela E. Potter
Department of Pharmacology
Arizona College of Osteopathic Medicine Midwestern University
19555 Glendale
AZ
USA


Shishu Huang
State Key Laboratory of Oral Diseases
Sichuan University
Chengdu
China


Yan Li
Center for Tansport Phenomena
Energy Research Institute of Shandong Academy of Sciences
Jinan
Shandong, 250014
China


Yat-Fung Shea
Department of Medicine, LKS Faculty of Medicine
University of Hong Kong, Queen Mary Hospital
Hong Kong
China


You-Qiang Song
School of Biomedical Sciences
The University of Hong Kong, Pokfulam
Hong Kong
China
/
State Key Laboratory of Brain and Cognitive Sciences
The University of Hong Kong, Pokfulam
Hong Kong
China


Zhi-Gang Zhang
School of Biomedical Sciences
The University of Hong Kong, Pokfulam
Hong Kong
China




RELATED BOOKS

.Frontiers in Clinical Drug Research-Dementia.
.Alzheimer
.Advances in Alzheimer Research.
.Cellular and Molecular Biology of Autism Spectrum Disorders.
.Alzheimer
.Advances in Alzheimer Research.
.Cellular and Molecular Biology of Autism Spectrum Disorders.
.Cellular Mechanisms in Alzheimer’s Disease.